ASN's Mission

To create a world without kidney diseases, the ASN Alliance for Kidney Health elevates care by educating and informing, driving breakthroughs and innovation, and advocating for policies that create transformative changes in kidney medicine throughout the world.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005

email@asn-online.org

202-640-4660

The Latest on X

Kidney Week

Please note that you are viewing an archived section from 2020 and some content may be unavailable. To unlock all content for 2020, please visit the archives.

Abstract: PO1507

Cleavage Fragments of Polycystin 1 Respond to Oxidative Stress and Alter Mitochondrial Dynamics and Function

Session Information

Category: Genetic Diseases of the Kidneys

  • 1001 Genetic Diseases of the Kidneys: Cystic

Authors

  • Pellegrini, Hannah, University of California Santa Barbara, Santa Barbara, California, United States
  • Sharpe, Elizabeth H., University of California Santa Barbara, Santa Barbara, California, United States
  • Weimbs, Thomas, University of California Santa Barbara, Santa Barbara, California, United States
Background

The PKD1 gene, which is mutated in ADPKD, encodes for the PC1 transmembrane protein containing a cytoplasmic C-terminal tail that undergoes cleavage at multiple sites. Two of these C-terminal fragments, a ~30 kDa fragment (p30), and a ~15 kDa fragment (p15) corresponding to the entire soluble C-terminal tail and the extreme end respectively, are overexpressed in patient kidneys.
Metabolic reprogramming is a hallmark of ADPKD. We demonstrate that the C-terminal fragments of PC1 respond to oxidative stress and contribute to metabolic reprogramming by altering mitochondrial dynamics.

Methods

MDCK and OK cell lines were generated stably expressing myc-tagged p30 or p15 under a doxycycline-inducible promoter
Protein levels of p30 were determined by western blot and localization by immunocytochemistry. Mitochondrial morphology was classified performing immunocytochemistry combined with image analysis. Fatty acid oxidation was assessed performing OilRedO staining and quantified by measuring the number of lipid droplets

Results

p30 normally undergoes rapid degradation and is stabilized in response to oxidative stress. Following glutamine starvation, p30 targets mitochondria and results in fragmentation. p15 does not undergo degradation and constitutively targets to the mitochondria where it induces mitochondrial fragmentation. Further, expressing p15 results in accumulation of lipid droplets indicative of impaired mitochondrial β-oxidation.

Conclusion

Our data unmasks p30 as a sensor of metabolic stress. We speculate that p30 stabilization and subsequent p15 cleavage are involved in metabolic reprogramming in ADPKD by altering mitochondrial morphology and function. Elucidating the exact underlying mechanisms is of major importance to understanding disease progression in ADPKD.